Quick Answer
INTERPACE BIOSCIENCES, INC. reported Total Assets of $33.84 million for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $33.84M | +128.8% |
| 2024 | $14.79M | +5.4% |
| 2024 | $14.04M | +8.2% |
| 2024 | $12.97M | +6.8% |
| 2024 | $12.14M | -7.4% |
| 2023 | $13.12M | -18.3% |
| 2023 | $16.06M | +0.5% |
| 2023 | $15.98M | +0.0% |
| 2022 | $15.98M | -58.4% |
| 2021 | $38.43M | -15.9% |
| 2020 | $45.68M | -11.4% |
| 2019 | $51.54M | +6.4% |
| 2018 | $48.44M | -9.6% |
| 2017 | $53.60M | +28.3% |
| 2016 | $41.78M | -38.3% |
| 2015 | $67.71M | -41.6% |
| 2014 | $115.91M | +67.8% |
| 2013 | $69.06M | -12.0% |
| 2012 | $78.45M | -30.8% |
| 2011 | $113.38M | -8.9% |
| 2010 | $124.39M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.04M | -14.3% | -2.4% |
| June 30, 2025 | $12.34M | -4.9% | -14.9% |
| March 31, 2025 | $14.49M | +19.4% | -2.0% |
| December 31, 2024 | $14.79M | +13.6% | +5.4% |
| September 30, 2024 | $14.04M | -1.5% | +8.2% |
| June 30, 2024 | $12.97M | -18.6% | +6.8% |
| March 31, 2024 | $12.14M | -23.5% | -6.8% |
| December 31, 2023 | $13.02M | -18.5% | -8.6% |
- INTERPACE BIOSCIENCES, INC. showed an increase of +128.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, INTERPACE BIOSCIENCES, INC.’s total assets has declined by 72.8% (from $124.39 million to $33.84 million).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: